Additionally, at 2 months post cessation of combination therapy, all long-term survivors rejected the re-implantation of chronic IFNγ pre-treated YUMM2.1 cells (Fig. 3D), indicating the induction of anti-tumour immune memory. Here, IFNG is linked to neoplasm.